Flora Growth Corp. appointed Brendan Cahill as an independent director and member of each of the Company's audit committee, compensation committee and nominating and corporate governance committee, effective May 2, 2024. As a result of Mr. Cahill's appointment to the Board and its audit committee, on May 6, 2024, the Company received a letter from The Nasdaq Stock Market LLC stating that the Company has regained compliance with the independent director and audit committee requirements for continued listing on The Nasdaq Capital Market set forth in Nasdaq Listing Rules 5605(b)(1) and 5605(c)(2) and that the matter is now closed.

Mr. Cahill was President and Chief Executive Officer of the Excellon Resources Inc. from 2012 to 2022. Previously, he was Vice President Corporate Development and Corporate Secretary of the Pelangio group of companies (until July 2012). He is currently a Director of Group Eleven Resources Corp.

and former director of KORE Mining Ltd. and Cryptostar Corp. He is a member of the Transplant Cabinet at the University Health Network and a member of the Law Society of Ontario.